Sphera Funds Management Ltd. Bluebird Bio, Inc. Transaction History

Sphera Funds Management Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$26.16 - $63.5 $1.69 Million - $4.1 Million	-64,500 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$46.96 - $61.67 $3.03 Million - $3.98 Million	64,500 New	64,500 $5.66 Million
Q3 2019 Nov 14, 2019	SELL	$59.47 - $93.1 $4.46 Million - $6.98 Million	-75,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$75.84 - $105.21 $667,088 - $925,427	-8,796 Reduced 10.5%	75,000 $0
Q1 2019 May 15, 2019	SELL	$64.44 - $104.11 $3.54 Million - $5.73 Million	-55,000 Reduced 39.63%	83,796 $13.2 Million
Q4 2018 Feb 14, 2019	BUY	$59.1 - $93.26 $3.57 Million - $5.63 Million	60,400 Added 77.04%	138,796 $13.8 Million
Q3 2018 Nov 14, 2018	BUY	$88.86 - $117.49 $525,429 - $694,718	5,913 Added 8.16%	78,396 $11.4 Million
Q2 2018 Aug 13, 2018	BUY	$99.64 - $127.59 $7.22 Million - $9.25 Million	72,483 New	72,483 $11.4 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.